Both in Pharmaceuticals
Vistagen Therapeutics vs BioVie
Over the past year VTGN returned −91.6% and BIVI returned −19.4%; their daily moves had a correlation of 0.05.
VTGN −91.6% BIVI −19.4%Growth of $1, one year, split-adjusted
| Metric | VTGN | BIVI |
|---|---|---|
| Price | $0.2980 | $1.54 |
| Market cap | $13.2M | $13.1M |
| Today | +0.34% | 0.00% |
| 1 month | +17.8% | −28.7% |
| 6 months | −45.4% | +14.1% |
| Year to date | −55.0% | +32.8% |
| 1 year | −91.6% | −17.2% |
| Revenue growth (YoY) | +504.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −882.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.3× | — |
| Net cash | $31.7M | $9.0M |
| Dividend yield | — | — |
| Volatility (60d) | 111.9% | 200.2% |
| Short % of float | 6.3% | 14.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).